Lurasidone in the treatment of schizophrenia: A randomized, double-blind, placebo- and olanzapine-controlled study

Herbert Y. Meltzer*, Josephine Cucchiaro, Robert Silva, Masaaki Ogasa, Debra Phillips, Jane Xu, Amir H. Kalali, Edward Schweizer, Andrei Pikalov, Antony Loebel

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

215 Scopus citations

Fingerprint

Dive into the research topics of 'Lurasidone in the treatment of schizophrenia: A randomized, double-blind, placebo- and olanzapine-controlled study'. Together they form a unique fingerprint.

Keyphrases

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology